litlas
ログインアカウント作成

Gregory A. Daniels

1978–2025 年に発表

59
論文数
18,078
被引用数
39
h 指数
55
i10 指数

被引用数

Gregory A. Daniels の年別被引用数1990 年: 被引用 1 件1992 年: 被引用 1 件1994 年: 被引用 1 件1995 年: 被引用 1 件1997 年: 被引用 3 件1998 年: 被引用 3 件2000 年: 被引用 4 件2001 年: 被引用 8 件2002 年: 被引用 5 件2003 年: 被引用 5 件2004 年: 被引用 6 件2005 年: 被引用 11 件2006 年: 被引用 11 件2007 年: 被引用 11 件2008 年: 被引用 6 件2009 年: 被引用 6 件2010 年: 被引用 13 件2011 年: 被引用 18 件2012 年: 被引用 24 件2013 年: 被引用 45 件2014 年: 被引用 57 件2015 年: 被引用 110 件2016 年: 被引用 154 件2017 年: 被引用 172 件2018 年: 被引用 256 件2019 年: 被引用 787 件2020 年: 被引用 1,177 件2021 年: 被引用 1,200 件2022 年: 被引用 1,037 件2023 年: 被引用 767 件2024 年: 被引用 1,069 件2025 年: 被引用 504 件2026 年: 被引用 17 件1991 年は被引用が無いため表示していません1993 年は被引用が無いため表示していません1996 年は被引用が無いため表示していません1999 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,023 件、この内訳の 27.2%中国: 引用元論文 1,453 件、この内訳の 13.1%ドイツ: 引用元論文 628 件、この内訳の 5.6%イギリス: 引用元論文 608 件、この内訳の 5.5%イタリア: 引用元論文 573 件、この内訳の 5.1%フランス: 引用元論文 463 件、この内訳の 4.2%オーストラリア: 引用元論文 456 件、この内訳の 4.1%オランダ: 引用元論文 359 件、この内訳の 3.2%カナダ: 引用元論文 326 件、この内訳の 2.9%スペイン: 引用元論文 312 件、この内訳の 2.8%日本: 引用元論文 302 件、この内訳の 2.7%スイス: 引用元論文 299 件、この内訳の 2.7%
0%27.2%その他 20.9%

機関

分野

  • Medicine55.8%
  • Biochemistry, Genetics and Molecular Biology32.1%
  • Immunology and Microbiology9%
  • Engineering0.9%
  • Computer Science0.4%
  • Materials Science0.4%
  • その他1.4%

トピック

  • Cancer Immunotherapy and Biomarkers14.2%
  • CAR-T cell therapy research7.7%
  • Immunotherapy and Immune Responses7.4%
  • Cancer Genomics and Diagnostics4.1%
  • Virus-based gene therapy research3.4%
  • Cutaneous Melanoma Detection and Management3.3%
  • その他59.9%

共著者

全論文

検索で開く
  1. Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

    著者: James Larkin, Vanna Chiarion‐Sileni, René González, Jean‐Jacques Grob, Piotr Rutkowski, Christopher D. Lao, C. Lance Cowey, Dirk Schadendorf, John Wagstaff, Reinhard Dummer, Pier Francesco Ferrucci, Michael Smylie, David Hogg, Andrew F. Hill, Iván Márquez‐Rodas, John B.A.G. Haanen, Massimo Guidoboni, Michele Maio, Patrick Schöffski, Matteo S. Carlino, Célèste Lebbé, Grant A. McArthur, Paolo A. Ascierto, Gregory A. Daniels, Georgina V. Long, Lars Bastholt, Jasmine I. Rizzo, Ágnes Balogh, Andriy Moshyk, F. Stephen Hodi, Jedd D. Wolchok - New England Journal of Medicine 2019 被引用: 3,708

  2. Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma

    著者: Jedd D. Wolchok, Vanna Chiarion‐Sileni, René González, Jean‐Jacques Grob, Piotr Rutkowski, Christopher D. Lao, C. Lance Cowey, Dirk Schadendorf, John Wagstaff, Reinhard Dummer, Pier Francesco Ferrucci, Michael Smylie, Marcus O. Butler, Andrew Hill, Iván Márquez‐Rodas, John B.A.G. Haanen, Massimo Guidoboni, Michele Maio, Patrick Schöffski, Matteo S. Carlino, Célèste Lebbé, Grant A. McArthur, Paolo A. Ascierto, Gregory A. Daniels, Georgina V. Long, Tuba Öcek Baş, Corey Ritchings, James Larkin, F. Stephen Hodi - Journal of Clinical Oncology 2021 被引用: 1,104

  3. Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

    著者: Robert H.I. Andtbacka, Howard L. Kaufman, Frances A. Collichio, Thomas Amatruda, Neil Senzer, Jason Chesney, Keith A. Delman, Lynn E. S̄pitler, Igor Puzanov, Sanjiv S. Agarwala, Mohammed Milhem, Lee D. Cranmer, Brendan D. Curti, Karl D. Lewis, Merrick I. Ross, Troy H. Guthrie, Gerald P. Linette, Gregory A. Daniels, Kevin J. Harrington, Mark R. Middleton, Wilson H. Miller, Jonathan S. Zager, Yining Ye, Bin Yao, Li Ai, Susan Doleman, Ari M. Vanderwalde, Jennifer Gansert, Robert S. Coffin - Journal of Clinical Oncology 2015 被引用: 2,598

  4. Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

    著者: Aaron M. Goodman, Shumei Kato, Lyudmila Bazhenova, Sandip Pravin Patel, Garrett M. Frampton, Vincent A. Miller, Philip J. Stephens, Gregory A. Daniels, Razelle Kurzrock - Molecular Cancer Therapeutics 2017 被引用: 2,390

  5. Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells

    著者: Daniel Ramsköld, Shujun Luo, Yu-Chieh Wang, Robin Li, Qiaolin Deng, Omid R. Faridani, Gregory A. Daniels, Irina Khrebtukova, Jeanne F. Loring, Louise C. Laurent, Gary P. Schroth, Rickard Sandberg - Nature Biotechnology 2012 被引用: 1,664

  6. Cemiplimab in locally advanced cutaneous squamous cell carcinoma: results from an open-label, phase 2, single-arm trial

    著者: Michael R. Migden, Nikhil I. Khushalani, Anne Lynn S. Chang, Karl D. Lewis, Chrysalyne D. Schmults, Leonel F. Hernandez‐Aya, Friedegund Meier, Dirk Schadendorf, Alexander Guminski, Axel Hauschild, Deborah Jean Lee Wong, Gregory A. Daniels, Carola Berking, Vladimir Janković, Elizabeth Stankevich, Jocelyn Booth, Siyu Li, David M. Weinreich, George D. Yancopoulos, Israel Lowy, Matthew G. Fury, Danny Rischin - The Lancet Oncology 2020 被引用: 480

  7. Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial

    著者: Assuntina G. Sacco, Ruifeng Chen, Francis P. Worden, Deborah Jean Lee Wong, Douglas R. Adkins, Paul Swiecicki, Wanxing Chai‐Ho, Peter Oppelt, Debanjali Ghosh, Julie Bykowski, Alfredo Molinolo, Emily Pittman, Mónica V. Estrada, Kathryn A. Gold, Gregory A. Daniels, Scott M. Lippman, Amanda Natsuhara, Karen Messer, Ezra E.W. Cohen - The Lancet Oncology 2021 被引用: 258

  8. SD-101 in Combination with Pembrolizumab in Advanced Melanoma: Results of a Phase Ib, Multicenter Study

    著者: Antoni Ribas, Theresa Medina, Shivaani Kummar, Asim Amin, Anusha Kalbasi, Joseph J. Drabick, Minal Barve, Gregory A. Daniels, Deborah Jean Lee Wong, Emmett V. Schmidt, Albert F. Candia, Robert L. Coffman, Abraham C.F. Leung, Robert S. Janssen - Cancer Discovery 2018 被引用: 341

  9. Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition

    著者: Elizabeth I. Buchbinder, Janice P. Dutcher, Gregory A. Daniels, Brendan D. Curti, Sapna P. Patel, Shernan G. Holtan, Gerald Miletello, Mayer Fishman, René González, Joseph I. Clark, John M. Richart, Christopher D. Lao, Scott S. Tykodi, Ann W. Silk, David F. McDermott - Journal for ImmunoTherapy of Cancer 2019 被引用: 147

  10. Dabrafenib Versus Dabrafenib + Trametinib in BRAF -Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer: Results of a Randomized, Phase 2, Open-Label Multicenter Trial

    著者: Naifa L. Busaidy, Bhavana Konda, Lai Wei, Lori J. Wirth, Catherine Devine, Gregory A. Daniels, Jonas DeSouza, Ming Poi, Nathan D. Seligson, Maria E. Cabanillas, Jennifer A. Sipos, Matthew D. Ringel, Ann‐Kathrin Eisfeld, Cynthia Timmers, Manisha H. Shah - Thyroid 2022 被引用: 106

  11. Clinical Responses of Oncolytic Coxsackievirus A21 (V937) in Patients With Unresectable Melanoma

    著者: Robert H. I. Andtbacka, Brendan Curti, Gregory A. Daniels, Sigrun Hallmeyer, Eric D. Whitman, Jose Lutzky, Lynn E. Spitler, Karl Zhou, Praveen K. Bommareddy, Mark Grose, Meihua Wang, Cai Wu, Howard L. Kaufman - Journal of Clinical Oncology 2021 被引用: 94

  12. Intralesional SD-101 in Combination with Pembrolizumab in Anti-PD-1 Treatment-Naïve Head and Neck Squamous Cell Carcinoma: Results from a Multicenter, Phase II Trial

    著者: Ezra E.W. Cohen, Lisle Nabell, Deborah J. Wong, Terry Day, Gregory A. Daniels, Mohammed Milhem, Sanjeev Deva, Michael Jameson, Orlando Guntinas-Lichius, Mohammed Almubarak, Matthew Strother, Eric Whitman, Michael Chisamore, Cynthia Obiozor, Teresa Bagulho, Jose Gomez-Romo, Cristiana Guiducci, Robert Janssen, Erick Gamelin, Alain P. Algazi - Clinical Cancer Research 2021 被引用: 48

  13. Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma

    著者: Neil Senzer, Howard L. Kaufman, Thomas Amatruda, Mike Nemunaitis, Tony Reid, Gregory A. Daniels, René González, John A. Glaspy, Eric D. Whitman, Kevin J. Harrington, Howard Goldsweig, Tracey Marshall, Colin Love, Robert S. Coffin, John Nemunaitis - Journal of Clinical Oncology 2009 被引用: 615

  14. Cutaneous Melanoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

    著者: Daniel G. Coit, John A. Thompson, Mark R. Albertini, Christopher A. Barker, William E. Carson, Carlo M. Contreras, Gregory A. Daniels, Dominick J. DiMaio, Ryan C. Fields, Martin D. Fleming, Morganna Freeman, Anjela Galan, Brian Gastman, Valerie Guild, Douglas B. Johnson, Richard W. Joseph, Julie R. Lange, Sameer K. Nath, Anthony J. Olszanski, Patrick A. Ott, Aparna Priyanath Gupta, Merrick I. Ross, April K.S. Salama, Joseph J. Skitzki, Jeffrey A. Sosman, Susan M. Swetter, Kenneth K. Tanabe, Evan Wuthrick, Nicole R. McMillian, Anita M. Engh - Journal of the National Comprehensive Cancer Network 2019 被引用: 438

  15. Adoptive Transfer of MART-1 T-Cell Receptor Transgenic Lymphocytes and Dendritic Cell Vaccination in Patients with Metastatic Melanoma

    著者: Thinle Chodon, Begoña Comı́n-Anduix, Bartosz Chmielowski, Richard C. Koya, Zhongqi Wu, Martin Auerbach, Charles Ng, Earl Avramis, Elizabeth Seja, Arturo Villanueva, Tara A. McCannel, Akira Ishiyama, Johannes Czernin, Caius G. Radu, Xiaoyan Wang, David W. Gjertson, Alistair J. Cochran, Kenneth Cornetta, Deborah Jean Lee Wong, Paula Kaplan‐Lefko, Omid Hamid, Wolfram E. Samlowski, Peter A. Cohen, Gregory A. Daniels, Bijay Mukherji, Lili Yang, Jerome A. Zack, Donald B. Kohn, James R. Heath, John A. Glaspy, Owen N. Witte, David Baltimore, James S. Economou, Antoni Ribas - Clinical Cancer Research 2014 被引用: 253

  16. Bempegaldesleukin Plus Nivolumab in First-Line Metastatic Melanoma

    著者: Adi Diab, Scott S. Tykodi, Gregory A. Daniels, Michele Maio, Brendan D. Curti, Karl D. Lewis, Sekwon Jang, Ewa Kalinka‐Warzocha, Igor Puzanov, Alexander I. Spira, Daniel C. Cho, Shanhong Guan, Erika Puente-Poushnejad, Tuan Nguyen, Ute Hoch, Sue Currie, Wei Lin, Mary Tagliaferri, Jonathan Zalevsky, Mario Sznol, Michael E. Hurwitz - Journal of Clinical Oncology 2021 被引用: 81

  17. Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience

    著者: Maria Schwaederlé, Barbara A. Parker, Richard B. Schwab, Gregory A. Daniels, David Piccioni, Santosh Kesari, Teresa Helsten, Lyudmila Bazhenova, J Moreno Romero, Paul T. Fanta, Scott M. Lippman, Razelle Kurzrock - Molecular Cancer Therapeutics 2016 被引用: 184

  18. Hypermutated Circulating Tumor DNA: Correlation with Response to Checkpoint Inhibitor–Based Immunotherapy

    著者: Yulian Khagi, Aaron M. Goodman, Gregory A. Daniels, Sandip Pravin Patel, Assuntina G. Sacco, James M. Randall, Lyudmila Bazhenova, Razelle Kurzrock - Clinical Cancer Research 2017 被引用: 202

  19. Phase I Trial of Intravenous Oncolytic Vaccinia Virus (GL-ONC1) with Cisplatin and Radiotherapy in Patients with Locoregionally Advanced Head and Neck Carcinoma

    著者: Loren K. Mell, Kevin T. Brumund, Gregory A. Daniels, Sunil J. Advani, Kaveh Zakeri, Mary E. Wright, Sara-Jane N. Onyeama, Robert A. Weisman, Parag Sanghvi, Peter J. Martin, Aladar A. Szalay - Clinical Cancer Research 2017 被引用: 138

  20. Intratumoral oncolytic virus V937 plus ipilimumab in patients with advanced melanoma: the phase 1b MITCI study

    著者: Brendan D. Curti, Jon Richards, John Hyngstrom, Gregory A. Daniels, Mark B. Faries, Lynn G. Feun, Kim Margolin, Sigrun Hallmeyer, Mark Grose, Yiwei Zhang, Anlong Li, Robert H.I. Andtbacka - Journal for ImmunoTherapy of Cancer 2022 被引用: 29

  21. Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma

    著者: Mario Sznol, Pier Francesco Ferrucci, David Hogg, Michael B. Atkins, Pascal Wolter, Massimo Guidoboni, Célèste Lebbé, John M. Kirkwood, Jacob Schachter, Gregory A. Daniels, Jessica C. Hassel, Jonathan Cebon, Winald R. Gerritsen, Victoria Atkinson, L. Thomas, John McCaffrey, Derek G. Power, Dana Walker, Rafia Bhore, Joel Jiang, F. Stephen Hodi, Jedd D. Wolchok - Journal of Clinical Oncology 2017 被引用: 294

  22. PSGL-1 attenuates early TCR signaling to suppress CD8+ T cell progenitor differentiation and elicit terminal CD8+ T cell exhaustion

    著者: Jennifer L. Hope, Dennis C. Otero, Eun‐Ah Bae, Christopher J. Stairiker, Ashley B. Palete, Hannah A. Faso, Michelle Lin, Monique L. Henriquez, Sreeja Biswas Roy, Hyungseok Seo, Lei Xue, Eric S. Wang, Savio Chow, Roberto Tinoco, Gregory A. Daniels, Kevin Y. Yip, Alexandre Rosa Campos, Jun Yin, Peter D. Adams, Anjana Rao, Linda M. Bradley - Cell Reports 2023 被引用: 33

  23. Metastatic gastric cancer target lesion complete response with Claudin18.2-CAR T cells

    著者: Gregory P. Botta, Joseph Chao, H. Ma, Michael G. Hahn, Gloria Sierra, Jie Jia, Amanda Y Hendrix, Joy Nolte Fong, Audrey Ween, Peter Vu, Aaron Miller, Michael Y. Choi, Benjamin Heyman, Gregory A. Daniels, Dan S. Kaufman, Catriona Jamieson, Zonghai Li, Ezra E.W. Cohen - Journal for ImmunoTherapy of Cancer 2024 被引用: 31

  24. Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology

    著者: Christopher K. Bichakjian, Thomas Olencki, Sumaira Z. Aasi, Murad Alam, James Andersen, Rachel Blitzblau, Glen M. Bowen, Carlo M. Contreras, Gregory A. Daniels, Roy H. Decker, Jeffrey M. Farma, K.A. Fisher, Brian Gastman, Karthik Ghosh, Roy C. Grekin, Kenneth Grossman, Alan L. Ho, Karl D. Lewis, Manisha J. Loss, Daniel D. Lydiatt, Jane L. Messina, Kishwer S. Nehal, Paul Nghiem, Igor Puzanov, Chrysalyne D. Schmults, Ashok R. Shaha, Valencia D. Thomas, Yaohui G. Xu, John A. Zic, K Hoffmann, Anita M. Engh - Journal of the National Comprehensive Cancer Network 2018 被引用: 316